Frequently Asked Questions about Illumina, Inc. (ILMN)

Name: Illumina, Inc. (ILMN) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Illumina, Inc. (ILMN) do?

Accepted Answer

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive he...

Question 2

Is Illumina, Inc. (ILMN) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of ILMN reveals an Altman Z-Score of 4.36 and a Piotroski F-Score of 8/9. These metrics, combined with its 5-year revenue trend ($4.34B most recent), help investors decide if ILMN fits their risk profile.

Question 3

What is the current P/E ratio for ILMN?

Accepted Answer

As of the latest trading session, Illumina, Inc. (ILMN) has a trailing P/E ratio of 22.26.

Question 4

Who is the CEO of Illumina, Inc.?

Accepted Answer

The current Chief Executive Officer of Illumina, Inc. is Jacob Thaysen.

Question 5

What was ILMN's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Illumina, Inc. reported annual revenues of $4.34B (2025), $4.37B (2024), $4.50B (2023), $4.58B (2023), $4.53B (2022) respectively.

Question 6

Does ILMN pay a dividend?

Accepted Answer

Illumina, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does ILMN have?

Accepted Answer

In its latest reporting period, Illumina, Inc. generated $0.93B in Free Cash Flow against a total debt load of $2.55B.

Question 8

What is the Price-to-Book (P/B) ratio of Illumina, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Illumina, Inc. (ILMN) is currently 6.95.

Question 9

What is the Price-to-Sales (P/S) ratio of ILMN?

Accepted Answer

Based on trailing twelve-month data, Illumina, Inc. (ILMN) trades at a Price-to-Sales (P/S) ratio of 4.35.

Question 10

What is Illumina, Inc.'s Return on Equity (ROE)?

Accepted Answer

Illumina, Inc. (ILMN) has a Return on Equity (ROE) of 34.94%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	1.1B	0	-148M	931M	931M
2024-12	837M	370M	-128M	709M	339M
2023-12	478M	380M	-195M	282M	-97M
2023-01	392M	366M	-286M	106M	-260M
2022-01	545M	754M	-208M	337M	-417M